My Cart 0
Do not conform to the pattern of this world but be transformed by the renewing of your mind. Then you will be able to test and approve what God’s will is—his good, pleasing, and perfect will.
Romans 12:2-4 NIV
META HEALTH LIMITED
Meta Health Limited (META), formerly known as Metal Component Engineering Limited, was founded in 1987 in Singapore. With consistent focus on quality and engineering innovation, META has expanded its customer base by serving MNC (Multi-National-Corporation), EMS (Electronic Manufacturing Services), and SME (Small-Medium-Enterprise) globally.
META has recently diversified into healthcare technology and services with investment into Gainhealth Pte. Ltd., a direct-to-consumer and high-growth omnichannel health and wellness platform. Their healthcare segments now include (1) Primary & Homecare, (2) Central Pharmacy, (3) Clinical Nutrition distribution and (4) Infrastructure as a service (where they help medical institutes digitalise their operations)
Recent Developments
- 14 Feb 2025 REPL::Rights::Voluntary
- 12 Feb 2025 General Announcement::Results of the Rights Issue and Final Net Proceeds From the Rights Issue
- 24 Jan 2025 Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Changes in Interest of Director - Sim Mong Keang
- 24 Jan 2025 Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Changes in Interest of Director - Bernard Ng Kee Huat
- 22 Jan 2025 General Announcement::Rights Issue - Despatch of OIS Notification Letter and Application Forms
- 20 Jan 2025 REPL::Rights::Voluntary
- 09 Jan 2025 REPL::Rights::Voluntary
- 06 Jan 2025 REPL::Rights::Voluntary
- 03 Jan 2025 General Announcement::Update on Out-Of-Court Settlement Involving Wholly-Owned Subsidiaries
- 17 Dec 2024 General Announcement::Acquisition of Jas Medical - Issuance of Consideration Shares and Initial Introducer Shares
- 11 Dec 2024 General Announcement::Acquisition of 55% of Jas Medical Screening Centre Pte Ltd - Receipt of Listing and Quotation Notice
- 09 Dec 2024 Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest of Substantial Shareholders - Blue Ocean Capital Partners & Estate of Lin Wei
- 05 Dec 2024 Rights::Voluntary
- 04 Dec 2024 General Announcement::Entry Into Non-binding Term Sheet Relating to Potential Acquisition of Aios Bio Sciences Pte. Ltd.
- 28 Nov 2024 Response to SGX Queries::
- 28 Nov 2024 Asset Acquisitions and Disposals::Acquisition of 55% of Shares of Jas Medical Screening Centre Pte Ltd - Entry Into Supplemental Deeds
- 18 Nov 2024 Asset Acquisitions and Disposals::Acquisition of 55% Shares of Jas Medical Screening Centre Pte Ltd
- 13 Nov 2024 Financial Statements and Related Announcement::Third Quarter Results
- 10 Oct 2024 General Announcement::Entry Into Non-binding Term Sheet Relating to Potential Acquisition
- 10 Sep 2024 General Announcement::Update on Receipt of Originating Claim - Agreement to Settlement
Investment Merits
Proxy to the digitalization of healthcare in the region
- Central Pharmacy facilitates the delivery of medicine for likes of clinics and nursing homes to end patients
- Rising user base for E-pharmacy
- Provides platform for medical institutes looking to digitalise their operations under the IAAS segment
Clinical Nutrition Distribution to tap into the central pharmacy’s B2B network for distribution
- Distributing to over 600 repeat customers including retailers and F&B outlets, Meta Health’s distribution arm has room for further growth as it taps into its central pharmacy’s network for cross-selling opportunities
Infrastructure-as-a-service (IAAS) segment can be highly scalable and profitable
- In collaboration with other vendors including MedTel, Meta Health has successfully launched a comprehensive suite of software solutions to help medical institutes digitalise their operations without incurring heavy CAPE
In The News
- Meta Health appoints Bernard Ng as new chairman and CEO, eyes “strategic review” of existing business
- Meta-SG: Meta Health Ltd- Stock Price, Quote and News
- Meta- Health Reuters
Stock Information
(as of 02 September 2024)
| Price | Market Cap (SGDm) | Enterprise Value (SGDm) |
|---|---|---|
| SGD 0.0080 | 8.25 | 9.43 |
Key Financial Highlights
| Key Highlights | TTM (SGD) |
|---|---|
| Revenue | 1.48M |
| Net Income Available to Common | -1.96M |
| Profit Margin | 0.00% |
| Return on Assets | -6.52% |
| Return on Equity | -216.11% |
| Price/Sales (ttm) | 3.69 |
| Price/Book (mrq) | 4.26 |
| Enterprise Value/Revenue | 6.36 |
| Enterprise Value/EBITDA | -3.01 |
| Total Cash (mrq) | 1.93M |
| Total Debt/Equity (mrq) | — |
| Levered Free Cash Flow (ttm) | 1.76M |